Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 28 Issue 5 • September–October 2020

Meet the Newest NIH Members of the National Academy of Sciences

Mini Symposium Held to Honor John Schiller and Robert Tycko

BY THU-LAN LILY NGUYEN, NCI

On July 21, 2020, the NIH hosted a virtual mini symposium to honor the two NIH investigators who were elected to the National Academy of Sciences (NAS) this year: NIH Distinguished Investigator John Schiller (National Cancer Institute, NCI) and Senior Investigator Robert Tycko (National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK). The NAS is a private, nonprofit organization of the country’s leading researchers and is committed to furthering science in America. Its 2,404 members and 501 foreign associates are active contributors to the international scientific community. The number of current NIH colleagues who have been elected to the prestigious NAS is 50.

John T. Schiller, Ph.D., NCI

john schiller

CREDIT: RHODA BAER

John Schiller (NCI) helped develop human papillomaviruses (HPV) vaccines for the prevention of cervical cancer and other tumors caused by HPV.

John Schiller has made fundamental contributions to our understanding of the human papillomaviruses (HPV), the most common sexually transmitted infections in the United States. He helped develop the HPV vaccines for the prevention of cervical cancer and other tumors caused by HPV and is developing treatments for other sexually transmitted infections and chronic diseases, including cancer.

Schiller earned a Ph.D. in microbiology from the University of Washington (Seattle) before coming to NIH to work in Douglas Lowy’s lab at NCI in 1983. The two have worked together for more than 30 years and have been honored countless times for their pioneering work studying HPV and developing the HPV vaccines, with awards including the National Medal of Technology and Innovation from President Barack Obama and the Lasker-DeBakey Clinical Medical Research Award. Lowy is also a member of the NAS.

illustration

CREDIT: JOHN SCHILLER, NCI

One of Schiller’s projects involves using HPV virus-like particles (VLPs) as “guided missiles” to deliver anticancer drugs to tumors. He found that HPV VLP-IR700 conjugates (IR700 is an infrared dye) can kill cancer cells but only if the conjugates are bound to the cell surface (mediated through cell-surface heparan sulfate proteoglycans, HSPGs) and illuminated with a near-infrared laser. The treatment was successful in treating uveal melanoma (an eye cancer) in phase 1b/2 clinical trials and a phase 3 trial will start soon. The treatment will be tested on other cancers, too. Schiller is also hoping to bring such treatments to low-income settings—handheld ultrasound devices can be used, instead of lasers, to activate the infrared dye, for instance.

During the mini-symposium, Schiller described his research as well as his efforts to bring cancer treatments to low-income countries with limited resources and health-care infrastructure. These countries need simple, inexpensive, and safe interventions for disease. In one project, his research group is attempting to harness preexisting antiviral immunity to treat cancers.

In another project, he is collaborating with the National Institute on Aging to study the effects of injecting peptides derived from viral epitopes (molecular regions on the surface of antigens) into naturally occurring tumors in mice. The idea is that the immune system will recognize the viral epitopes expressed in cancers and recruit T cells that can fight the tumors. The initial results in mouse tumor models are promising, and he hopes that such general therapies can be used as off-the-shelf treatments for many types of cancerous tumors.

Robert Tycko, Ph.D., NIDDK

Robert Tycko

CREDIT: SASHA K. TYCKO

Biophysicist Robert Tycko (NIDDK) use of solid-state nuclear magnetic resonance (NMR) to investigate the structural properties of molecules has provided new insights into the structure and physical behavior of proteins associated with Alzheimer disease, type 2 diabetes, and AIDS.

Robert Tycko is a biophysicist who uses solid-state nuclear magnetic resonance (NMR) to investigate the structural properties of molecules important to human biology and disease. His research has provided new insights into the structure and physical behavior of proteins associated with Alzheimer disease, type 2 diabetes, and AIDS.

Tycko completed a Ph.D. in chemistry at the University of California at Berkeley (Berkeley, California) and did his postdoctoral training at the University of Pennsylvania (Philadelphia). He then worked as a member of the technical staff at AT&T Bell Laboratories (Murray Hill, New Jersey) for eight years before coming to NIH as a senior investigator in 1994. His development of NMR technology served as a way to bridge his interests in math, physics, chemistry, and building things. At NIH, he roped in biology, too, and explored the biological applications of NMR.

images

CREDIT: ROBERT TYCKO, NIDDK

Transmission electron microscope image of amyloid-beta fibrils derived from human Alzheimer's disease brain tissue (left) and cross-sectional view of a molecular structural model for these fibrils based on solid state nuclear magnetic resonance data (right). Hydrophobic, polar, negatively charged, and positively charged amino acid sidechains in the molecular model are colored green, magenta, red, and blue.

He recognized the potential of using solid-state NMR and electron microscopy to study protein structures such as the amyloid-beta fibrils that develop in brain tissue of people with Alzheimer disease. Not much was known about the fibrils when Tycko began studying them. Over the years, he has been able to characterize the structure and identify distinct morphologies of amyloid-beta fibrils. Now examining the implications on human health, his lab studies fibrils extracted from patients with Alzheimer disease to see how differing morphologies may affect pathogenesis. Tycko continues to play an instrumental role in developing technologies in structural biology to shed light on the molecular world.

To see a videocast of the National Academy of Sciences Mini Symposium 2020, go to https://videocast.nih.gov/watch=38191.


Lily Nguyen

Lily Nguyen is a postbaccalaureate fellow in the National Cancer Institute’s Laboratory of Molecular Biology. After she completes her training in 2021, she hopes to go to graduate school to pursue a Ph.D. in molecular biology. In her spare time, she’s an avid TV and movie watcher and enjoys going to picturesque places and documenting them on film.

This page was last updated on Tuesday, March 22, 2022

  • Issue Overview
  • Features
    • NIH and Howard University Partnership
    • Diagnosing Traumatic Brain Injuries
    • Using Flatworm Regeneration To Study Stem Cells
    • Meet the Newest NIH Members of the National Academy of Sciences
    • COVID-19 Timeline at NIH (July–August 2020)
    • Herb Tabor (1918–2020)
  • Departments
    • From the Deputy Director for Intramural Research
    • The Training Page: Commentary
    • News Briefs
    • The SIG Beat: COVID-19
    • Research Briefs
    • Colleagues: Recently Tenured
    • The Training Page: OITE Train-the-Trainer
    • The Training Page: New Family Leave Policy
    • Announcements
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search